person

Hassan S.

Country
Germany
Department
Acute Neurology / Stroke Unit and Intensive Care

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
135
Sites with multiple studies

Has run more than one trial at 135 of 455 partner sites.

Specializations

Stroke Prevention and Management

This investigator specializes in the treatment and prevention of acute ischemic stroke and transient ischemic attack (TIA), with particular emphasis on developing innovative therapeutic approaches for stroke prevention.

  • Non-cardioembolic ischemic stroke management
  • High-risk TIA treatment strategies
  • Secondary stroke prevention

The research focus includes evaluating novel therapeutic agents for preventing recurrent strokes in high-risk patients.

Antithrombotic Therapies

The investigator conducts research on advanced antithrombotic treatments, particularly focusing on novel oral anticoagulants and their role in stroke prevention.

  • Factor XIa inhibitor research
  • Antiplatelet therapy optimization
  • Combined antithrombotic approaches

Their work explores the efficacy of new therapeutic agents in combination with established antiplatelet treatments.

Clinical Safety Assessment

The investigator specializes in evaluating the safety profiles of new therapeutic agents, with particular attention to bleeding risk assessment in stroke prevention treatments.

  • Bleeding risk evaluation
  • Safety monitoring protocols
  • Risk-benefit assessment

Their research includes systematic evaluation of bleeding risks according to International Society on Thrombosis and Hemostasis criteria.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.